Aakaar Medical Technologies Ltd. - Laporan Laba Rugi (TTM)

Aakaar Medical Technologies Ltd.
IN ˙ NSEI
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Aakaar Medical Technologies Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2021
03-31
2022
03-31
2023
03-31
2024
03-31
2025
03-31
Revenue 124 195 328 461 616
Change (%) 56.50 68.43 40.65 33.55
% of Revenue 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 63 91 150 210 262
Change (%) 43.72 64.84 39.97 24.84
% of Revenue 50.93 46.77 45.78 45.56 42.58
Gross Operating Profit 61 104 178 251 354
Change (%) 69.76 71.57 41.22 40.85
% of Revenue 49.07 53.23 54.22 54.44 57.42
SG&A 30 40 77 129 129
Change (%) 31.31 94.36 66.51 0.26
% of Revenue 24.35 20.43 23.57 27.91 20.95
R&D
Change (%)
% of Revenue
OpEx 113 170 292 412 519
Change (%) 50.47 71.38 41.12 26.18
% of Revenue 90.94 87.44 88.97 89.27 84.34
Operating Income 11 24 36 49 96
Change (%) 117.06 47.85 36.83 94.92
% of Revenue 9.06 12.56 11.03 10.73 15.66
Interest Expense -4 -0 -4 -10 -16
Change (%) -92.94 1,111.41 174.60 59.08
% of Revenue -3.39 -0.15 -1.10 -2.15 -2.56
Net Income 5 18 22 29 60
Change (%) 230.59 19.65 33.30 110.42
% of Revenue 4.38 9.25 6.57 6.22 9.81

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista